Health Updates From - March 2016





Welcome to the first newsletter of 2016. Hope your 2016 has gone off to flying start, and you have made some serious health commitments for this year. 


As a new feature in this newsletter, we are highlighting important studies from the last several months - year, which are of interest to our patient population.


On the news front, from our practice, I was recently invited to deliver grand rounds to the Cedars-Sinai spine Institute. During this lecture, I highlighted the exciting biologic therapies that we have available for rheumatoid arthritis. However, we also highlighted the difficulties of these medications for spine surgery, I'm hopeful that this dialogue can lead to better care for rheumatoid arthritis patients who undergo spine surgery.


We have continued our collaboration with the Brigham & Women's Hospital, and have implemented objective data collection for our patients at the point of care, and using this objective data to make decisions about changing rheumatoid arthritis medications. This has been a very fruitful collaboration that has taught our office a lot about how to provide high quality care using objective measures to direct chronic disease care.


Our research program has also continued, and currently I am enrolling patients for a clinical trial of tocilizumab for the treatment of myositis. We have multiple clinical trials that are open and enrolling in lupus, and we're continuing to study the genes of patients in Sjogren's syndrome. If you're interested in participating, or know of someone who might be interested in participating in this cutting-edge research, please have them contact the office at 310-659-9959 or by e-mail at


Be healthy!


Sincerely Swamy Venuturupalli, MD.

product image


Rheumatoid Arthritis

Medication Conundrum

Swamy Venuturupalli, MD

The recent death of Glenn Frey of the Eagles has caught everyone's attention. Particularly, comments made by his manager, alleging that his arthritis medications caused ulcerative colitis and then a life threatening pneumonia have resulted in a lot of anxiety and nervousness among patients who suffer from rheumatoid arthritis. Our office has received numerous calls asking for clarification on this topic, and many of my patients are concerned about the potential side effects of the medications that they are on. I thought that it would be a good time to address this issue and communicate on this topic.



Nutrition and SLE

Laura Corrales-Diaz and Swamy Venuturupalli, MD

This is a topic that I am very passionate about. Among the numerous patients with severe lupus that I have treated, I have found that those patients who are attentive to their nutrition tend to do better.

product image




As a new feature of our correspondence, I'm enclosing the results of recent clinical trials in the field of rheumatology with my comments. As I review studies regularly, I thought that sharing what I read and my analysis may be beneficial to all of you. As always I would appreciate your feedback.


- Swamy Venuturupalli, MD.




Walk to Cure Arthritis


Saturday, May 15th 2016, Exposition Park, 7.30 am.


8737 Beverly Blvd, Suite 302

Los Angeles, CA 90048

facebook icon
twitter icon